Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

US Medical Device Makers Target China’s 2nd and 3rd Tier Markets

publication date: Oct 26, 2012
As China’s major metropolitan areas become more competitive, US medical device makers are turning their attention to the second and third tier cities. For Medtronic, the changed emphasis drove the company to purchase Kanghui Holdings, a China device company, because of Kanghui’s well-established sales connections in smaller cities and rural areas. GE Healthcare is following a different route: developing primary care products for smaller basic care providers. More details....

Stock Symbols: (NYSE: MDT) (NYSE: KH) (NYSE: GE)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital